Young David 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Young David（CIK 1378166）在 1 家公司共报告 8 笔 SEC Form 4 内部人交易（最近一笔 2026-07-01）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-07-01 | Processa Pharmaceuticals, Inc. (PCSA) | Pres. Research & Development | 买入 | 2,531 | $4,885 |
| 2026-06-16 | Processa Pharmaceuticals, Inc. (PCSA) | Pres. Research & Development | 买入 | 2,067 | $4,589 |
| 2026-06-01 | Processa Pharmaceuticals, Inc. (PCSA) | Pres. Research & Development | 买入 | 1,786 | $4,590 |
| 2026-05-19 | Processa Pharmaceuticals, Inc. (PCSA) | Pres. Research & Development | 买入 | 1,545 | $4,589 |
| 2026-05-01 | Processa Pharmaceuticals, Inc. (PCSA) | Pres. Research & Development | 买入 | 1,706 | $4,589 |
| 2026-04-17 | Processa Pharmaceuticals, Inc. (PCSA) | Pres. Research & Development | 买入 | 1,545 | $4,589 |
| 2026-04-01 | Processa Pharmaceuticals, Inc. (PCSA) | Pres. Research & Development | 买入 | 1,810 | $4,597 |
| 2026-02-04 | Processa Pharmaceuticals, Inc. (PCSA) | Pres. Research & Development | 买入 | 49 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-07-01